Dermapharm Holding SE (DMP)
XHAN
Closed
Aug 25, 2026
Day's Range
39.6052 wk Range
31.85Overview - DMP - Dermapharm Holding SE
Key Statistics
Valuation
Enterprise Value
848.87M
P/E (Trailing)
‪16.09‬
PEG Ratio
‪0.45‬
Price / Book
‪2.89‬
EV / EBITDA
‪2.59‬
Profitability
Gross Margin
‪67.92%‬
Profit Margin
‪67.20%‬
Operating Margin
‪19.93%‬
Return on Assets
‪6.05%‬
Return on Equity
‪19.16%‬
Ownership
Shares Outstanding
53.84M
Price stats
50-Day Avg
‪43.30‬
200-Day Avg
‪41.40‬
Dividends
Frequency
Annual
Peers - DMP - Dermapharm Holding SE
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XHAN.
- DMPXHANDermapharm Holding SE+15.62%52-week change16.14P/E (Trailing)‪67.20%‬Profit Margin
- PBFXHANPictet-Biotech-P USD+40.76%52-week change—P/E (Trailing)—Profit Margin
- LDZAXHANAspen Pharmacare Holdings Limited+32.67%52-week change-3.08P/E (Trailing)‪44.11%‬Profit Margin
- ANLXHANAnalog Devices, Inc.+32.46%52-week change69.63P/E (Trailing)‪61.46%‬Profit Margin
- PARXHANParker-Hannifin Corporation+24.61%52-week change31.04P/E (Trailing)‪36.85%‬Profit Margin
- MRKXHANMerck KGaA+21.10%52-week change23.02P/E (Trailing)‪58.50%‬Profit Margin
- BONXHANBoiron SA+16.86%52-week change13.56P/E (Trailing)‪72.98%‬Profit Margin
Profile Summary - DMP - Dermapharm Holding SE
About
Dermapharm Holding SE is a leading manufacturer of branded pharmaceuticals and other healthcare products, founded in 1991 by Wilhelm Beier and headquartered in Grünwald near Munich, Germany. The company operates an integrated business model encompassing in-house product development, production, quality management, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
